Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 14, 2023 at 12:36 pm IST
Share
Ahn-Gook Pharmaceutical Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported negative sales was KRW 0.00021 million compared to sales of KRW 0.00049 million a year ago. Net income was KRW 657.63 million compared to KRW 3,876.99 million a year ago. Basic earnings per share from continuing operations was KRW 58 compared to KRW 341 a year ago. Diluted earnings per share from continuing operations was KRW 58 compared to KRW 341 a year ago. Basic earnings per share was KRW 58 compared to KRW 341 a year ago.
For the nine months, negative sales was KRW 0.00029 million compared to sales of KRW 0.00039 million a year ago. Net income was KRW 4,036.37 million compared to KRW 6,330.45 million a year ago. Basic earnings per share from continuing operations was KRW 355 compared to KRW 556 a year ago. Diluted earnings per share from continuing operations was KRW 355 compared to KRW 556 a year ago. Basic earnings per share was KRW 355 compared to KRW 556 a year ago.
AHN-GOOK PHARMACEUTICAL Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. It also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The Company distributes its product within domestic market and to overseas markets.